(Q67714497)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1726210%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Microbiological evaluation of cefpodoxime proxetil (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1726210%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Microbiological Evaluation of Cefpodoxime Proxetil (English)

1 reference

10.2165/00003495-199100423-00004

Crossref

DOI

https://api.crossref.org/works/10.2165/00003495-199100423-00004

9 November 2022

author name string

B. Wiedemann

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1726210

9 November 2022

E. Luhmer

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1726210

9 November 2022

M. T. Zühlsdorf

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1726210

9 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1726210

9 November 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1726210%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1726210%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

42 Suppl 3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1726210%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

6-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1726210%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-199100423-00004

17 September 2019

exact match

0 references

cites work

In vitro activity of cefpodoxime proxetil (U-76,252; CS-807) against Neisseria gonorrhoeae

1 reference

12 December 2020

In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.

1 reference

12 December 2020

In vitro activity of cefpodoxime and ten other cephalosporins against gram-positive cocci, Enterobacteriaceae and Pseudomonas aeruginosa, including beta-lactamase producers

1 reference

12 December 2020

Antibacterial activity of cefpodoxime proxetil in a pharmacokinetic in-vitro model.

1 reference

12 December 2020

In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin

1 reference

12 December 2020

Antimicrobial activity of U-76,252 (CS-807), a new orally administered cephalosporin ester, including recommendations for MIC quality control

1 reference

12 December 2020

In vitro evaluations of U-76,252 (CS-807): antimicrobial spectrum, beta-lactamase stability, and enzyme inhibition

1 reference

12 December 2020

In vitro activity of U-76,252 (CS-807), a new oral cephalosporin

1 reference

12 December 2020

New In Vitro Model to Study the Effect of Antibiotic Concentration and Rate of Elimination on Antibacterial Activity

1 reference

12 December 2020

Antibacterial activities of cefpodoxime, cefixime, and ceftriaxone

1 reference

12 December 2020

Studies on orally active cephalosporin esters

1 reference

12 December 2020

In vitro activity of cefpodoxime, a new oral cephalosporin

1 reference

12 December 2020

In vitro activity of cefpodoxime proxetil (U-76,252; CS-807) against clinical isolates of Branhamella catarrhalis

1 reference

12 December 2020